Zobrazeno 1 - 10
of 11
pro vyhledávání: '"35"'
Autor:
Joana Bücker, Márcia Kauer-Sant'Anna, Gabriel Rodrigo Fries, Ingrid Borba Hartmann, Ellen Scotton, Lisia von Diemen
Publikováno v:
Surgery for Obesity and Related Diseases. 12:1554-1560
Background Bariatric surgery is the most effective treatment choice for severe obesity. Recent literature indicates that FK506-binding protein 51 (FKBP51) could play a role in energy homeostasis, influencing adipogenesis and weight. Objective To eval
Publikováno v:
Surgery for Obesity and Related Diseases. 3:127-132
Background: To perform a prospective, randomized comparison of laparoscopic adjustable gastric banding (LAGB) and laparoscopic Roux-en-Y gastric bypass (LRYGB). Methods: LAGB, using the pars flaccida technique, and standard LRYGB were performed. From
Publikováno v:
Surgery for Obesity and Related Diseases. 16:2006-2015
Background Morbidly obese patients often suffer from gastroesophageal reflux disease (GERD). High-resolution impedance manometry (HRIM) allows a comprehensive evaluation of esophageal motility and esophagogastric junction (EGJ) morphology and helps t
Publikováno v:
Surgery for Obesity and Related Diseases. 14:1561-1569
Exclusion of the proximal gut from nutrient absorption entails significant metabolic benefits. The duodenal-jejunal bypass liner (DJBL) is the first endoscopic device that excludes the first part of the gut by covering it.To assess weight and glycemi
Publikováno v:
Surgery for Obesity and Related Diseases. 14:490-497
Background Few series are available concerning repeat sleeve gastrectomy (re-SG), and series have reported contradictory results concerning morbidity rates, with limited data concerning weight loss. Objective Evaluate the short- and medium-term outco
Publikováno v:
Surgery for Obesity and Related Diseases. 14:144-149
Bariatric procedures are increasingly being used, but data on bowel habits are scarce.To assess changes in gastrointestinal function and patient-scored symptoms after Roux-en-Y gastric bypass (RYGB) and biliopancreatic diversion with duodenal switch
Autor:
Ali Aminian, Saeed Shoar, Philip R. Schauer, Zhamak Khorgami, Amin Andalib, Stacy A. Brethauer
Publikováno v:
Surgery for Obesity and Related Diseases. 13:774-778
Background Bariatric surgery is the most effective treatment for morbid obesity. Furthermore, the proportion of various types of bariatric procedures has significantly changed over the last two decades. Sleeve gastrectomy (SG) has been increasingly c
Autor:
Stacy A. Brethauer, Jacob A. Petrosky, Amin Andalib, Ali Aminian, Philip R. Schauer, Zhamak Khorgami
Publikováno v:
Surgery for Obesity and Related Diseases. 13:273-280
Background Fast track recovery pathways have resulted in a multidisciplinary approach to enhance postoperative recovery. Objectives To assess feasibility and outcome of early discharge after laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux
Publikováno v:
Surgery for Obesity and Related Diseases. 12:1594-1600
Background: Long-term data on health-related quality of life (HRQL) after biliopancreatic diversion with duodenal switch (BPDDS) are scarce. The aim of this study was to evaluate changes in HRQL from baseline to 10 years in patients who had undergone
Publikováno v:
Surgery for Obesity and Related Diseases. 9:390-394
Background A small, but significant, number of patients undergoing bariatric surgery refuse blood transfusion for religious or other personal reasons. Jehovah's Witnesses number more than 1 million members in the United States alone. The reported rat